-
Benserazide is a
peripherally acting aromatic L-amino acid
decarboxylase or DOPA
decarboxylase inhibitor,
which is
unable to
cross the blood–brain barrier...
- Levodopa/
benserazide, sold
under the
brand name
Prolopa among others, is a fixed-dose
combination medication used for the
treatment of Parkinson's disease...
-
aromatic L-amino acid
decarboxylase (AAAD)
inhibitor like
carbidopa or
benserazide.
Levodopa is
taken by mouth, by inhalation,
through an
intestinal tube...
-
aromatic L-amino acid
decarboxylase (AAAD)
inhibitor such as
carbidopa or
benserazide.
These agents increase the
strength and
duration of levodopa. Combination...
-
synthesized benserazide, an
inhibitor of DOPA decarboxylase,
which further reduced the
required dose. A drug
combining L-DOPA with
benserazide was marketed...
-
Examples of
extracerebral decarboxylase inhibitors include carbidopa and
benserazide.
Peripherally selective DDCIs incapable of
crossing the
protective blood–brain...
-
aromatic L-amino acid
decarboxylase (AAAD)
inhibitor such as
carbidopa or
benserazide.
These agents increase the
strength and
duration of oxitriptan. An investigational...
- an
aromatic L-amino acid
decarboxylase inhibitor (e.g.
carbidopa or
benserazide). The
therapeutic benefit of
using a COMT
inhibitor is
based on its ability...
- such as
carbidopa and
benserazide to
restrict metabolism and
activation in the periphery. Carbidopa/levodopa and levodopa/
benserazide are used to increase...
-
dopamine deficiencies.
Along with carbidopa,
other DDC
inhibitors are
benserazide (Ro-4-4602), difluoromethyldopa, and α-methyldopa. Carbidopa, an inhibitor...
